Filtered By:
Drug: Nicotine
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 22 results found since Jan 2013.
Fight Aging! Newsletter, May 2nd 2016
This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer). With the assurance that each patient gets the same mixture of cells, the researchers were able to come to conclusions about the effects of administering different doses of cells.
In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Of the two participants who did n...
Source: Fight Aging! - May 1, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
A Brace of Articles on Cryonics
I can only speculate as to why a set of better than usual articles on the non-profit cryonics industry have appeared in various popular press publications recently. I pointed out one of them yesterday, and here I'll offer links to another two. While attention from the press tends to come and go in cycles, the past decade, and especially the last few years, has seen a considerable improvement in the quality and tenor of coverage: popular science articles on cryonics providers and human interest pieces on the community of supporters and advocates. This is probably due to a number of factors, among which are the slow burn of ...
Source: Fight Aging! - April 29, 2016 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
Fight Aging! Newsletter, April 18th 2016
This study confirms that having an apple-shaped body - or a high waist circumference - can lead to heart disease, and that reducing your waist size can reduce your risks."
The results of the new research expands on the results of a previously published study called FaCTor-64, which showed that the greater a person's body mass index, the greater their risk of heart disease. FaCTor-64 enrolled patients with diabetes who were considered to be at high risk for heart attacks, strokes, or death but had no evidence of heart disease as of yet. Study participants completed randomized screening for coronary artery disease by ...
Source: Fight Aging! - April 17, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
The Rider Institute Seeks Funding for DRACO Research
Double-stranded RNA activated caspase oligomerizer, DRACO is an antiviral technology that works by destroying infected cells rather than directly attacking viral particles themselves, thus disrupting viral replication. It has proven effective against numerous viruses, and should in principal work against near all viral infections in a broad range of species, including the many persistent viral infections that presently lack any effective treatment. The technology finds itself in a similar position to SENS rejuvenation research however, with little support from the funding mainstream, and needing to raise funds from philant...
Source: Fight Aging! - April 11, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Integrity In Retail Health Care: Rethinking The Sale Of Tobacco Products
TweetRetail health care is a relatively new development in American health care. It is true that much of the dispensing of medications has historically occurred through retail pharmacies, which sold a variety of other goods and services, but somehow that was not seen as the provision of health care. Health care institutions, including doctors’ offices, hospitals and clinics, were the places that people went to be diagnosed and treated. And those institutions did little other than health care; they did not, and still do not today, offer any products other than provision of care, including testing and treatment. ...
Source: Health Affairs Blog - September 3, 2014 Category: Health Management Authors: Troyen Brennan, William Shrank, and Andrew Sussman Tags: All Categories Business of Health Care Consumers Health Care Delivery Pharma Policy Public Health Science and Health Substance Abuse Source Type: blogs
NIH and Other Public Private Partnerships to Research Treatments for Multiple Diseases
Over the past few weeks, the National Institutes of Health (NIH) has made a number of important announcements regarding collaborations with industry as well as the funding of several new research initiatives. Below is a summary of these stories.
NIH Partners With Eli Lilly and Others on Rare Diseases
FierceBiotechResearch reported that NIH selected four (4) new preclinical drug development studies to uncover new therapies for rare diseases. The projects will be funded through the Therapeutics for Rare and Neglected Diseases (TRND) program under NIH's National Center for Advancing Translational Sciences, NCATS, which ...
Source: Policy and Medicine - October 4, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
Sharing data from clinical trials: where we are and what lies ahead -BMJ
BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f4794 (Published 30 July 2013)Cite this as: BMJ 2013;347:f4794Elizabeth Loder, associate editorAuthor Affiliationseloder@bmj.comThe drive to make clinical trial data more accessible has garnered widespread international support, but rearguard actions by the drug industry could delay substantial change. Elizabeth Loder looks at international developments in the sharing of clinical trial dataAlmost a decade ago an Italian scientist, Alessandro Liberati, wrote an impassioned Personal View in the BMJ. He had developed myeloma and need...
Source: PharmaGossip - July 30, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
